marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-12-2024
Caladrius Biosciences Financial Ratios 2011-2024 | CLBS
Annual Financial Ratios Caladrius Biosciences
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.2 | -0.0 | -0.1 | -4.0 | -1.6 | -2.9 | 1.7 | -0.8 | -0.3 | -2.1 | -3.9 | -1.6 | -1.1 |
P/S |
- | - | - | - | - | - | - | 0.8 | 1.2 | 6.5 | 10.4 | 6.2 | 0.7 |
EPS |
-2.6 | -10.5 | -7.5 | -0.5 | -1.9 | -1.7 | 2.6 | -5.0 | -1.7 | -1.7 | -1.9 | -0.4 | -0.5 |
EV (Enterprise Value) |
-12.3 M | -23.2 M | -17.1 M | 20 M | 23.3 M | 43.8 M | 22.1 M | 60.5 M | 40.3 M | 165 M | 134 M | 96 M | 125 M |
EBITDA per Share |
-3.16 | -11.1 | -7.86 | -1.24 | -1.94 | -1.73 | -3.04 | -4.37 | -10.1 | -17 | -17.2 | -20.8 | -29.5 |
EV/EBITDA |
0.7 | -0.9 | -0.8 | -2.2 | -0.3 | -0.7 | -0.5 | -2.0 | -3.1 | -2.7 | -2.2 | ||
PEG |
-0.0 | -0.0 | -0.0 | -0.06 | 0.13 | 0.02 | 0.01 | -0.01 | -0.55 | -0.18 | -0.07 | -0.06 | 0.07 |
P/B |
0.1 | 0.0 | 0.0 | 1.0 | 1.5 | 1.3 | 0.8 | 6.7 | 1.1 | 2.0 | 2.5 | 2.7 | 0.7 |
P/CF |
-0.2 | -0.1 | -0.1 | -3.7 | -1.6 | -2.3 | -1.8 | -1.0 | -0.6 | -2.3 | -5.1 | -6.1 | -2.0 |
ROE % |
-43.28 | -81.45 | -29.77 | -25.28 | -94.20 | -43.16 | 45.78 | -803.06 | -347.39 | -94.49 | -62.85 | -163.83 | -58.82 |
ROA % |
-38.10 | -74.25 | -28.31 | -22.64 | -71.30 | -36.27 | 36.26 | -63.00 | -141.40 | -43.45 | -43.40 | -98.83 | -30.35 |
ROCE % |
-53.39 | -86.52 | -31.49 | -58.91 | -94.88 | -43.60 | -51.04 | -96.92 | -142.51 | -52.48 | -46.01 | -68.35 | -29.53 |
Current Ratio |
8.0 | 10.9 | 19.4 | 10.1 | 4.3 | 7.8 | 6.6 | 1.3 | 1.4 | 2.2 | 5.2 | 1.7 | 1.1 |
DSO |
- | - | - | - | - | - | - | 29.9 | 41.7 | 63.3 | 46.3 | 26.8 | 32.4 |
DIO |
- | - | - | - | - | - | - | - | - | - | 35.8 | 34.0 | 111.9 |
DPO |
- | - | - | - | - | - | - | 51.2 | 74.4 | 131.8 | 94.6 | 78.1 | 67.9 |
Operating Cycle |
- | - | - | - | - | - | - | 29.9 | 41.7 | 63.3 | 82.1 | 60.8 | 144.2 |
Cash Conversion Cycle |
- | - | - | - | - | - | - | -21.3 | -32.7 | -68.5 | -12.5 | -17.2 | 76.3 |
All numbers in USD currency
Quarterly Financial Ratios Caladrius Biosciences
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.59 | -0.61 | -0.65 | - | -0.65 | -0.5 | -0.77 | - | -7.88 | -1.64 | -1.05 | - | -1.74 | -0.1 | -0.19 | - | -0.29 | 0.5 | -0.38 | - | -0.47 | -0.49 | -0.44 | - | -0.36 | -0.42 | -0.52 | - | -0.38 | 4.34 | -1.12 | - | -1.09 | -1.33 | -2.09 | -0.59 | -2.06 | -3.84 | -0.51 | -0.32 | -0.48 | -0.4 | -0.49 | -0.47 | -0.45 | -0.46 | -0.53 | - | -0.64 | -1.53 | -0.08 | - | -0.08 | -0.13 | -0.14 |
EBITDA per Share |
-0.64 | -0.66 | -0.79 | - | -0.73 | -0.85 | -0.85 | - | -7.94 | -1.66 | -1.64 | - | -1.74 | -0.12 | -0.19 | - | -0.29 | -0.32 | -0.38 | - | -0.48 | -0.51 | -0.46 | - | -0.36 | -0.43 | -0.53 | - | -0.64 | -0.84 | -0.69 | - | -0.85 | -1.21 | -1.8 | - | -1.54 | -5.48 | -0.47 | - | -0.42 | -0.36 | -0.46 | - | -0.4 | -0.4 | -0.3 | - | -0.42 | -0.37 | -0.04 | - | -0.05 | -0.08 | -0.04 |
ROE % |
-50.36 | -45.71 | -39.50 | -27.15 | -79.24 | -121.34 | -122.43 | -64.94 | -71.98 | -26.93 | -24.28 | -19.77 | -36.16 | -45.51 | -19.79 | -8.37 | -31.90 | -39.03 | -84.03 | -69.20 | -78.61 | -64.49 | -50.60 | -33.43 | -40.45 | -38.07 | 48.90 | 49.74 | -99.47 | -241.67 | -479.27 | -557.34 | -557.48 | -408.32 | -246.94 | -0.34 | -0.22 | -0.20 | -0.15 | -0.09 | -0.09 | -0.08 | -0.07 | -0.06 | -25.39 | -50.73 | -112.52 | -115.33 | -127.18 | -113.67 | -68.96 | -45.34 | -11.84 | -17.10 | -16.40 |
ROA % |
-45.01 | -41.16 | -35.77 | -24.84 | -72.45 | -110.99 | -109.16 | -56.84 | -63.60 | -18.13 | -23.36 | -19.02 | -33.82 | -41.86 | -18.30 | -7.55 | -25.59 | -28.83 | -66.09 | -53.05 | -61.01 | -50.93 | -41.15 | -28.29 | -33.88 | -31.52 | 38.32 | 39.64 | 26.02 | 18.00 | -57.42 | -51.60 | -51.65 | -38.06 | -23.35 | -0.14 | -0.09 | -0.09 | -0.07 | -0.04 | -0.05 | -0.04 | -0.04 | -0.04 | -15.49 | -30.94 | -68.62 | -70.33 | -75.06 | -64.33 | -33.47 | -18.11 | -4.73 | -6.83 | -6.55 |
ROCE % |
- | - | - | - | -52.56 | -105.11 | -113.29 | -68.24 | -75.32 | -29.84 | -28.47 | -21.22 | -37.69 | -47.07 | -53.47 | -42.16 | -66.52 | -74.42 | -86.90 | -72.11 | -82.08 | -67.69 | -53.32 | -34.97 | -47.10 | -49.26 | -53.21 | -40.14 | -157.41 | -262.55 | -398.92 | -495.64 | -539.43 | -465.94 | -422.55 | -228.31 | -256.09 | -240.09 | -153.09 | -64.75 | -77.14 | -61.75 | -51.43 | -33.09 | -51.14 | -56.80 | -61.08 | -50.08 | -57.61 | -47.10 | -42.36 | -25.37 | -7.53 | -10.46 | -7.37 |
Current Ratio |
8.0 | 9.3 | 8.8 | 8.0 | 10.8 | 13.4 | 11.8 | 10.9 | 11.6 | - | 28.4 | 19.4 | 24.9 | 27.6 | 24.9 | 9.6 | 9.6 | 9.6 | 9.6 | 4.1 | 4.1 | 4.1 | 4.1 | 6.3 | 6.3 | 6.3 | 6.3 | 4.8 | 4.8 | 4.8 | 4.8 | 1.8 | 1.8 | 1.8 | 1.8 | 1.7 | 0.9 | 1.7 | 1.7 | 1.9 | 1.8 | 1.9 | 1.9 | 3.2 | - | 3.2 | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 19.1 | - | 1.4 | 16.7 | 33.2 | 30973.1 | 39.8 | 39.9 | 81.7 | 53810.4 | 69.0 | 63.2 | 55.9 | 41638.3 | 45.8 | 39.0 | 52.7 | - | 21.7 | 28.5 | 18.2 | - | 42.4 | 155.7 | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 47.5 | 43.5 | 32.8 | - | 27.6 | 27.4 | 45.5 | - | 27.1 | 37.1 | 27.2 | - | 31.2 | 453.6 | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 20.2 | - | 23.6 | 42.7 | 62.1 | - | 77.9 | 64.6 | 132.3 | - | 128.8 | 140.5 | 107.5 | - | 102.9 | 72.3 | 112.7 | - | 62.2 | 85.2 | 74.8 | - | 110.3 | 319.1 | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 19.1 | - | 1.4 | 16.7 | 33.2 | 30973.1 | 39.8 | 39.9 | 81.7 | 53810.4 | 116.4 | 106.8 | 88.7 | 41638.3 | 73.4 | 66.3 | 98.1 | - | 48.8 | 65.6 | 45.4 | - | 73.6 | 609.3 | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -1.2 | - | -22.2 | -26.0 | -28.8 | 30973.1 | -38.2 | -24.7 | -50.7 | 53810.4 | -12.3 | -33.7 | -18.8 | 41638.3 | -29.5 | -6.0 | -14.6 | - | -13.4 | -19.6 | -29.4 | - | -36.8 | 290.2 | - |
All numbers in USD currency